Given our previous demonstration that EGCG suppresses inflammation by modulating the TXNIP/NLRP3/IL‐1β axis in vitro, we hypothesized that EGCG might similarly reduce inflammation in DKD mice through this pathway. The gene discussed is TXNIP; the disease is diabetic kidney disease.